TCL Archive NCAB Rejects Automatic Loss Of Comprehensive Status For Center Without Core Grants September 29, 1978
TCL Archive NCAB Votes Down Dietary Fat Study In women; Proposal highly Recommended By Study Section September 29, 1989
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
